In this online CME self-learning program:
The hemodynamic status of critically ill patients is complex often with complicating co-morbidities. As a result there are often conflicting therapeutic goals involved, such as maintaining hemodynamic instability and fluid management with ALI/ARDS. The challenges to managing septic shock are to find the right parameters to monitor and the end-points for adequate resuscitation. Current evidence supports the use of dynamic parameters rather than traditional static ones for fluid responsiveness. When caring for the complex patient, caveats with traditional assessment variables exist. Clinicians need to become more aware of new developments in managing septic shock. This session discusses current evidence for use of dynamic parameters in a goal directed approach to resolve sepsis, as well as caveats around other parameters used in goal directed resuscitation, such as ScvO2 and lactate levels.
This program has been designed for a multidisciplinary physician and nurse audience including: ICU / Anesthesia / Peri-op / Intensivists / Trauma / Critical Care
This program is supported by an educational grant from Edwards Lifesciences, a manufacturer of Medical Devices.
Release Date: December 01, 2010 -- Expiration Date: November 30, 2011
Faculty: Jorge A Guzman, MD, FCCM -- Byron Bair, M.D. -- Laxman Bahroo, MD -- Claudia Baldassano, MD
agenda goes here
By the end of the session the participant will be able to:
ACCME Activity #accme #
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
Faculty Disclosure and Resolution of COI: As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Jorge A Guzman, MD, FCCM discloses that he receives honoraria and expense reimbursement from Edwards Lifesciences.
Disclosures of Educational Planners: Steven Sachse is an officer and part owner of ScientiaCME, LLC. ScientiaCME has received grants from Bayer, Edwards Lifesciences, Eisai, Daiichi-Sankyo, Lilly, Merck, Pfizer, Sanofi Aventis, Wolf-Torey Medical, and currently has grants pending from from Abbott, AMGEN, BMS, Eisai, and Savient Pharmaceuticals.
Commercial Support Disclosure: This program is supported by an educational grant from Edwards Lifesciences, a manufacturer of Medical Devices.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.
TEST-Multiple Sclerosis - From Who Gets It to How Much Does it Cost to Treat
Multiple Sclerosis - From Who Gets It to How Much Does it Cost to Treat